Skip to main navigation
Close
Menu
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Breadcrumb
Association for Accessible Medicines
Resources
Press Releases
Press Release
Share
Press Release
Jun 18, 2021
| Rachel Schwartz
AAM Statement on Governor Mill’s Consideration of LD 1117
Press Release
Jun 17, 2021
| Rachel Schwartz
AAM and Biosimilars Council Statement on ACA Ruling in California v. Texas
Press Release
Jun 16, 2021
| Rachel Schwartz
AAM Statement on Maine LD 1117
Press Release
Jun 8, 2021
| Rachel Schwartz
AAM Statement on Biden-Harris Administration’s 100-Day Supply Chain Review
Press Release
May 26, 2021
| Rachel Schwartz
Black Women’s Health Imperative Named AAM’s 2021 “Champion of Access”
Press Release
May 24, 2021
| Erica Klinger
AAM Names Erik Komendant Senior Vice President, Government Affairs
Press Release
May 24, 2021
| Rachel Schwartz
Steven Selde Joins AAM’s Biosimilars Council as Director
Press Release
May 17, 2021
| Rachel Schwartz
Monét Stanford Joins AAM as Director, Policy
Press Release
Apr 29, 2021
| Rachel Schwartz
AAM Statement on The Protecting Access to Affordable Medicines Act
Press Release
Apr 27, 2021
| Rachel Schwartz
AAM Statement on the Ensuring Access to Lower-Cost Medicines for Seniors Act
Press Release
Apr 22, 2021
| Rachel Schwartz
SB 764 Will Hurt Oregon's Most Vulnerable Patients
Press Release
Mar 25, 2021
| Rachel Schwartz
AAM Statement on IQVIA Report Examining Biosimilar Reimbursement and Adoption
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2024
GRx+Biosims 2023
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action